LexBlog IP

MARCH 8, 2023

We also have an upcoming webinar covering the topic in March – details here.) What seems clear is that NAD is reading this document with a fine-tooth comb, and one can expect to see this guidance followed to a tee as far as what is expected from advertisers for all manner of health claim substantiation.

Advertising 52

Advertising Advertising Branding Brands 52

SpicyIP

OCTOBER 26, 2022

After a few sessions on conceptual and theoretical ideas around IP, this set of sessions will now take the class on a different not-so-theoretical topic and deliberates upon IP issues that crop up around clinical trial test data, drug innovation, Indian drug regulatory regulation etc. Does it provide the benefits it claims to?

IP 118

IP Invention Patent Marketing 118

Patently-O

FEBRUARY 15, 2023

The Federal Circuit weighed in on the amorphous topic of subject matter eligibility in the recent opinion ChromaDex, Inc., Claim one of ‘807 states: 1. Although the claims require isolated NR, they do not require a specific high-concentration, only enough to “increase[] NAD+ biosynthesis upon oral administration.”

Patent 56

Patent Patent Drafting IP Law 56

Bio Law Blog

NOVEMBER 15, 2021

The Patent Trial and Appeal Board did not institute IPR of the ’807 patent but instituted IPR of the ’086 patent and upheld one of the challenged claims as valid. The court held the asserted claims are directed to a natural phenomenon because NR is a naturally occurring vitamin present in cow milk. § 101. ” Id.

Patent 52

Patent Invention Litigation Contracts 52

43(B)log

JULY 20, 2023

As a fact witness, the government agreed that he could supply what he claims is “the scientific basis upon which he made the alleged misstatements” for the purpose of assessing whether he had sufficient substantiation for his claims. The evidence didn’t support the claim that the websites were used as educational references.

Government 52

Government Advertising Advertising Social Media 52

Biswajit Sarkar Copyright Blog

MARCH 1, 2024

The topic of interest is related to both the cellular and molecular aspects of biological objects. Details of the inventions, the best method of performing them, and the claims for which inventors seek protection should be mentioned specifically and clearly in patent applications. Who can file a patent application?

Patent 92

Patent Inventor Invention Intellectual Property 92

43(B)log

AUGUST 9, 2021

5, 2021) Scilex sells an FDA-approved, prescription-strength topical analgesic self-adhesive patch, ZTlido (lidocaine), which is allegedly often prescribed off-label, including for general neuropathic pain (e.g., Must the plaintiff allege its own reliance to prevail on its UCL/FAL claims? back and spinal pain). Matkari, 7 F.3d

False Advertising 59

False Advertising Advertising Advertising Marketing 59